The presence of individual matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in different histological types of gastric cancer
| Diffuse type (n=27) | Intestinal type (n=47) | All tumours (n=74) | |
| MMP-1 | |||
| Strong | 6 (22) | 22 (47) | 28 (38) |
| Weak | 9 (33) | 17 (36) | 26 (35) |
| Absent | 12 (45) | 8 (17) | 20 (27) |
| Total | 27 (100) | 47 (100) | 74 (100) |
| MMP-2 | |||
| Strong | 21 (78) | 42 (91) | 63 (85) |
| Weak | 4 (15) | 3 (5) | 7 (9) |
| Absent | 2 (7) | 2 (4) | 4 (6) |
| Total | 27 (100) | 47 (100) | 74 (100) |
| MMP-3 | |||
| Strong | 1 (4) | 2 (4) | 3 (4) |
| Weak | 4 (15) | 13 (28) | 17 (23) |
| Absent | 22 (81) | 32 (68) | 54 (73) |
| Total | 27 (100) | 47 (100) | 74 (100) |
| MMP-9 | |||
| Strong | 8 (30) | 22 (47) | 30 (41) |
| Weak | 9 (33) | 19 (40) | 28 (38) |
| Absent | 10 (37) | 6 (13) | 16 (21) |
| Total | 27 (100) | 47 (100) | 74 (100) |
| TIMP-1 | |||
| Strong | 2 (7) | 8 (17) | 10 (14) |
| Weak | 7 (26) | 13 (28) | 20 (27) |
| Absent | 18 (67) | 26 (55) | 44 (59) |
| Total | 27 (100) | 47 (100) | 74 (100) |
| TIMP-2 | |||
| Strong | 5 (19) | 7 (16) | 12 (16) |
| Weak | 10 (37) | 20 (42) | 30 (41) |
| Absent | 12 (44) | 20 (42) | 32 (43) |
| Total | 27 (100) | 47 (100) | 74 (100) |
Results are expressed as number (%).